LUPIN has announced its results for the quarter ended September 2020. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-19* | 3 Jun-20* | 3 Sep-20* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 43,597 | 35,279 | 38,350 | 8.7% | -12.0% |
Other income | Rs m | 1,333 | 433 | 250 | -42.3% | -81.3% |
Turnover | Rs m | 44,929 | 35,711 | 38,600 | 8.1% | -14.1% |
Expenses | Rs m | 36,286 | 30,398 | 32,538 | 7.0% | -10.3% |
Gross profit | Rs m | 1,846 | 4,881 | 5,812 | 19.1% | 214.9% |
Depreciation | Rs m | 3,215 | 2,146 | 2,127 | -0.9% | -33.8% |
Interest | Rs m | 865 | 443 | 336 | -24.0% | -61.1% |
Profit before tax | Rs m | -901 | 2,725 | 3,598 | 32.1% | |
Tax | Rs m | 343 | 1,643 | 1,467 | -10.7% | 327.7% |
Profit after tax | Rs m | -1,244 | 1,081 | 2,131 | 97.0% | |
Gross profit margin | % | 4.2 | 13.8 | 15.2 | ||
Effective tax rate | % | -38.1 | 60.3 | 40.8 | ||
Net profit margin | % | -2.8 | 3.0 | 5.5 |
To see how LUPIN has performed over the last eight quarters,please visit here.
Know More: Which way are the markets & the mutual fund industry headed?
Over the last one year, LUPIN share price has moved up from Rs 772.2 to Rs 920.7, registering a Gain of Rs 148.6 or around 19.2%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,704.0 (down 0.4%). Over the last one year it has moved up from 13,231.2 to 19,704.0, a gain of 6,473 points (up 48.9%).
Overall, the S&P BSE SENSEX is up 3.6% over the year.
At the current price of Rs 920.7, the price to book value (P/BV) ratio of LUPIN stands at 3.0 times.
Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.
For the quarter ended March 2020, LUPIN has posted a net profit of Rs 4 bn (up 35.5% YoY). Sales on the other hand came in at Rs 38 bn (down 12.7% YoY). Read on for a complete analysis of LUPIN's quarterly results.
Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.
More Views on NewsIn this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More
| |
Equitymaster requests your view! Post a comment on "LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!